Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma

Abstract

Background Colon adenocarcinoma (COAD) is one of the most common malignant tumors, with high incidence and mortality rates worldwide. Reliable prognostic biomarkers are needed to guide clinical practice. Methods Comprehensive gene expression with alternative splicing (AS) profiles for each patient was downloaded using the SpliceSeq database from The Cancer Genome Atlas. Cox regression analysis was conducted to screen for prognostic AS events. The R package limma was used to screen differentially expressed genes (DEGs) between normal and tumor samples in the COAD cohort. A Venn plot analysis was performed between DEGs and prognostic AS events, and the DEGs that co-occurred with prognostic AS events (DEGAS) were identified. The top 30 most-connected DEGAS in protein–protein interaction analysis were identified through Cox proportional hazards regression to establish prognostic models. Results In total, 350 patients were included in the study. A total of 22,451 AS events were detected, of which 2004 from 1439 genes were significantly associated with survival time. By overlapping these 1439 genes with 6455 DEGs, 211 DEGs with AS events were identified. After the construction of the protein–protein interaction network, the top 30 hub genes were included in a multivariate analysis. Finally, a risk score based on 12 genes associated with overall survival was established ( P < 0.05). The area under the curve was 0.782. The risk score was an independent predictor ( P < 0.001). Conclusions By exploring survival-associated AS events, a powerful prognostic predictor consisting of 12 DEGAS was built. This study aims to propose a novel method to provide treatment targets for COAD and guide clinical practice in the future.

Prognostic and clinicopathological importance of microRNA-140 expression in cancer patients: a meta-analysis

“…Given that the environment cannot be improved in a short time period, researchers have committed to discovering mechanisms underlying the occurrence and development of cancer and finding treatment breakthroughs. Fortunately, in recent years, new advances in the knowledge of genes and proteins and the development of surgical procedures and adjuvant therapies have, to a certain extent, reduced the impact of cancer [ 30 – 32 ]. Based on the current research focus on miRNAs, this we aimed to find a therapeutic direction to further improve the prognosis of tumor patients.…”

Alterations of RNA splicing patterns in esophagus squamous cell carcinoma

“…Using PSI (percent spliced in) and DEXSeq methods, 28 pairs of colorectal cancer and normal tissues were analyzed, where 9 significant AS genes were found with two splicing events associated with patient overall survival [ 12 ]. Applying public data from TCGA, more than 200 DEGs (Differentially Expressed Genes) with AS events were identified and a risk score based on 12 genes associated with overall survival was established in colon adenocarcinoma[ 13 ]. In kidney renal clear cell carcinoma, 13 survival-specific genes were significantly correlated with AS events from SpliceSeq database [ 14 ].…”

Bioinformatics, Molecular Docking Simulation and in vitro Experiments Reveal the Bioactive Compounds and Mechanism of Coptis chinensis Franch. Against Colorectal Adenocarcinoma

“…Colorectal adenocarcinoma (COAD) is a prevalent and lethal form of digestive tract cancer with high incidence and mortality rates (Dang et al, 2020). Annually, millions of people are diagnosed with COAD, and many die from the disease (Qu et al, 2020). Although treatments like surgery, radiotherapy, chemotherapy, and medication have improved cure rates for early-stage COAD patients, the five-year survival rate remains low for those with locally advanced COAD.…”